School-Based Tele-Physiatry Assistance for Rehabilitative and Therapeutic Services (STARS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03320122|
Recruitment Status : Recruiting
First Posted : October 25, 2017
Last Update Posted : January 23, 2019
|Condition or disease||Intervention/treatment||Phase|
|Pediatrics Physical and Rehabilitation Medicine Physical Therapy Modalities||Other: Telemedicine Other: In-Person Pediatric Physiatrist Other: In-Person Non-Pediatric Physiatrist||Not Applicable|
During this study, a novel model of care will be developed and tested using telehealth technologies to bring necessary medical expertise to children with special health care needs living in rural and underserved communities. This model of care will be implemented in eight school-based Medical Therapy Units (MTUs) in northern California using a randomized design. The investigators hypothesize that this model of care will result in 1) equal satisfaction of the care received in-person from pediatric physiatrists and increased satisfaction of the care received from non-pediatric specialists; 2) equal adherence rates to an evidence-based hip surveillance program when compared to children who receive care from in-person pediatric physiatry care and better adherence than children who receive care from non-pediatric specialists; and 3) cost savings when compared to medical direction provided in-person by pediatric physiatrists and non-pediatric specialist providers.
The first 6 months of the project will be a "ramp-up" period during which the protocol will be re-reviewed during MTU site visits and necessary contracts and approvals will be in place. The last 6 months will be reserved for data analysis, study closeout, and manuscript preparation. The intervention phase will include various designs of implementation. For those schools currently without pediatric physiatry services, the investigators will provide MTU services using telemedicine and add in-person clinics. For those schools where medical direction is provided by non-pediatric physiatrists, the investigators will augment current services using telemedicine to provide medical direction to some children using pediatric physiatrists. For those schools where pediatric physiatrists travel long distances to provide medical direction during scheduled clinics, the investigators will similarly add additional telemedicine services such that an augmented mixed model of in-person and telemedicine pediatric physiatrist medical direction will be provided.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||350 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||The proposed program will target MTUs and patients in counties were pediatric physiatrists and other multidisciplinary team members are underrepresented. In this proposed model, the investigators will randomly select at least 350 patient encounters: approximately 175 children will receive care using tele-physiatrist medical direction; 101 children will receive care from a pediatric physiatrist who travels to the MTU to provide in-person care; and 74 children will receive care under a non-pediatric specialist's medical directorship. Once the care model has been created at each site, patients from each cohort will be selected using a clustered, clinic based randomization scheme.|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||School-Based Tele-Physiatry Assistance for Rehabilitative and Therapeutic Services for Children With Special Health Care Needs Living in Rural and Underserved Communities|
|Actual Study Start Date :||February 1, 2017|
|Estimated Primary Completion Date :||July 31, 2022|
|Estimated Study Completion Date :||July 31, 2022|
Medical Direction will be provided by pediatric physiatrists using telemedicine.
Medical direction will be provided to MTUs through a video-based conferencing unit. Each telemedicine unit includes a Rubbermaid medical grade cart with a Polycom RealPresence 500 Series high-resolution video-conferencing unit flat screen to display video. Each cart also comes with an Uninterrupted Power Supply (UPS) to make the unit mobile if needed or to properly shut it down in the event of power failure.
Active Comparator: In-Person Pediatric Physiatrist
Medical Direction will be provided by pediatric physiatrists in-person.
Other: In-Person Pediatric Physiatrist
UC Davis pediatric physiatrists will drive out to the school-based MTUs to provide medical direction in person.
Active Comparator: In-Person Non-Pediatric Physiatrist
Medical Direction will be provided by contracted physicians (i.e., non-pediatric physiatrists) in-person care.
Other: In-Person Non-Pediatric Physiatrist
A contracted physician (i.e., a non pediatric physiatrist) would provide medical direction in person.
- Parent/Guardian Satisfaction Survey [ Time Frame: Over 1 day for each patient ]The effect of providing pediatric physiatrist medical direction across groups will be measured through satisfaction surveys that will be distributed to participating parents and guardians. Satisfaction surveys will utilize a seven-point Likert scale and the investigators will assess the inter-item reliability, dimensionality and construct validity of satisfaction scales using standard multivariable analysis techniques. A higher score represents a higher satisfaction rate. The investigators postulate that a minimally important clinically significant difference is approximately 0.50 points, while a difference of 0.30 is tolerably close for purposes of non-inferiority.
- Evidence-Based Hip Surveillance Program Survey [ Time Frame: Over 1 day for each patient ]The hip surveillance survey utilizes several Yes/No responses to compare guideline adherence between the three cohorts and the questions are directly linked to the clinical expectations and explicit guidelines for the appropriate timing and frequency of x-rays and exams. Adherence rates will be compared by adjusted odds ratios.
- European Quality of Life-5 Dimensions (EQ-5D) Survey [ Time Frame: Over 1 day for each patient ]The EQ-5D is a quality of life assessment tool for measuring "utility." The "utility" is a comprehensive health measure, ranging from 0 (death) to 1 (perfect health), based on an individual's health state in five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The utility for a certain health condition is calculated by applying an established formula that assigns weights to each of the levels in each dimension determined by this health condition. These data on a quality of life will be used in a cost-effectiveness analysis.
- Economic Efficiency [ Time Frame: Up to 4 years ]Cost analysis will estimate cost changes resulting from the introduction of this new model of care from the perspectives of patients and families, physicians and healthcare providers, and payers. The proposed economic evaluative methods will integrate all of the effectiveness results from patient encounter data and EQ-5D survey data. Cost analysis will estimate return-on-investment indicating the cost-saving amount per $1 investment in telemedicine compared to MTUs without telemedicine.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03320122
|Contact: Jamie Kissee, MAemail@example.com|
|United States, California|
|University of California, Davis, Medical Center||Recruiting|
|Sacramento, California, United States, 95817|
|Contact: Jamie L Kissee, MA 916-734-4933 firstname.lastname@example.org|
|Principal Investigator: James P Marcin, MD, MPH|
|Sub-Investigator: Thomas Nesbitt, MD, MPH|
|Sub-Investigator: Nathan Kuppermann, MD, MPH|
|Principal Investigator:||James Marcin, MD, MPH||UC Davis Health|